The short version
- In a 2018 Cell study using direct mucosal sampling, probiotics after antibiotics produced a markedly delayed and persistently incomplete return of participants' own gut microbiome compared with spontaneous recovery.
- In that same study, autologous faecal microbiome transplant produced a rapid and near-complete recovery within days, and Lactobacillus-secreted soluble factors inhibited the native community in vitro.
- A 2025 Cochrane review of 47 trials in 15,260 people found probiotics may reduce Clostridioides difficile-associated diarrhoea from 3.2% to 1.6%, an absolute risk reduction of 1.6% on low-certainty evidence.
- That absolute reduction means roughly 60 people would need to take a probiotic for one to avoid C. difficile diarrhoea at the trials' baseline risk.
- Twenty-eight of the studies in the Cochrane review had an author affiliation with or funding from a probiotic company, and around 30% lacked a published protocol or trial registration.
"Take a probiotic afterwards to build your gut back up" is the single most repeated piece of pharmacy-counter advice in this category. We sell probiotics, so we benefit from it. Here is the study that complicates it, which we would rather you heard from us than from a stranger's thread.
The Cell paper
In 2018, Suez and colleagues published work in Cell that did something most probiotic research does not: it looked inside people. Rather than relying on stool samples alone, they used endoscopy to sample the gut mucosa directly, in humans and in mice, after a course of antibiotics. Three arms: spontaneous recovery, a multi-strain probiotic, or autologous faecal microbiome transplant — the participant's own pre-antibiotic microbiome, collected beforehand and given back.
The first finding was that antibiotics made probiotics colonise better. Compared with baseline health, the perturbed human mucosa was noticeably more hospitable to the supplemented strains. That sounds like good news for the product.
The second finding is the one that matters. Compared with letting recovery happen on its own, probiotics induced a markedly delayed and persistently incomplete return of the participants' own indigenous stool and mucosal microbiome, and of their gut gene expression, toward its normal configuration. Autologous transplant, by contrast, produced a rapid and near-complete recovery within days. In laboratory work, soluble factors secreted by Lactobacillus contributed to the inhibition of the native community.
The authors' conclusion is worth reading slowly: potential post-antibiotic probiotic benefits may be offset by a compromised gut mucosal recovery.
What that study does and does not say
It does not say probiotics are harmful. It measured recolonisation and gene expression, not symptoms, and it did not show anyone getting ill. It is one study, with a small human sample, using one multi-strain product. Nobody has replicated it at scale, and a single elegant study is exactly the kind of thing this blog spends other articles telling you not to over-read.
But it is a well-designed study asking a question the industry had largely skipped, and it got an inconvenient answer. Publishing that is the price of asking you to trust the rest of what we print.
The other side, which is also real
There is a genuine reason to take a probiotic with antibiotics, and it is narrower than "rebuilding your gut."
The 2025 Cochrane review on preventing Clostridioides difficile-associated diarrhoea pooled 47 trials in 15,260 participants. From 38 trials in 13,179 people, probiotics may produce an absolute risk reduction of 1.6% — 1.6% incidence on probiotics against 3.2% on control — a relative risk reduction of 50% (RR 0.50, 95% CI 0.38–0.64), on low-certainty evidence.
Halving the risk sounds decisive. The absolute numbers are the ones to decide on: at that baseline rate, roughly 60 people need to take the probiotic for one of them to avoid C. difficile diarrhoea. In a hospitalised 80-year-old on broad-spectrum intravenous antibiotics, whose baseline risk is far higher, that trade is clearly worth making. In a healthy 30-year-old on five days of amoxicillin for a dental abscess, whose baseline risk is very low, it is a different calculation entirely.
The review authors also note their own housekeeping problems: around 30% of the included studies lacked a published protocol or trial registration, and 28 had an author affiliation with, or funding from, a probiotic company.
So what would we actually do?
Split the decision by who you are.
- High risk — older, hospitalised, broad-spectrum or prolonged antibiotics, previous C. difficile: the Cochrane evidence supports taking one, and this is a conversation to have with the prescribing clinician rather than with us.
- Low risk — otherwise healthy, short narrow-spectrum course at home: the case is much weaker, and the Cell paper is a reason not to reflexively take one for weeks afterwards.
If you do take one, the strain designation on the label carries the evidence, not the CFU count — and the trials that produced the C. difficile result used specific organisms, not "50 billion, 12 strains". Take it during the course rather than for months after, and let your own community come back.
The unglamorous alternative is food. Fermented foods and a decent fibre intake feed what is already there rather than competing with it, and prebiotics are the substrate that your own returning bacteria use. That is not a product recommendation, which is rather the point.
And if things have not settled a few weeks after the course — persistent diarrhoea, blood, fever, or bloating that is new and will not shift — that is a doctor's appointment. Post-antibiotic C. difficile is a real diagnosis with real treatment. And if what is left behind is months of unpredictable bloating, work through the causes of bloating properly rather than escalating your probiotic — that list includes things a stool test finds and a capsule does not. Gut symptoms that persist after an infection also sit squarely on the gut-brain axis, which is treated with therapy and neuromodulators rather than with more bacteria.
Good questions
Should I take a probiotic after antibiotics?
It depends far more on your risk than most advice admits. If you are older, hospitalised, or on broad-spectrum or prolonged antibiotics, the Cochrane evidence supports it for preventing C. difficile diarrhoea. If you are a healthy adult on a short home course, the benefit is small and one well-designed study found probiotics delayed the return of your own gut bacteria.
Do probiotics really delay microbiome recovery?
One 2018 Cell study found exactly that, using endoscopy to sample the gut lining rather than relying on stool. Compared with letting recovery happen naturally, probiotics produced a markedly delayed and persistently incomplete return of the participants' own microbiome. It is a single study with a small human sample and it has not been replicated at scale, but it asked a question the industry had skipped.
When should I take the probiotic, during or after the course?
During, if you are taking one for C. difficile prevention, since that is when the trials gave it. The Cell finding is specifically about the post-antibiotic recolonisation window, which is an argument against carrying on for months afterwards in the belief that you are rebuilding something. Let your own community come back.
Is a higher CFU count better after antibiotics?
No. The trials behind the C. difficile result used specific named organisms at specific doses, and the strain designation is what carries the evidence. A label that advertises 50 billion across 12 unnamed strains is telling you a manufacturing figure and nothing about whether that combination has ever been tested.
What can I do instead of a probiotic?
Eat for the bacteria you already have. Fermented foods and an adequate fibre intake feed the returning native community rather than competing with it, and they cost nothing extra. That is a deliberately unprofitable answer from a company that sells probiotics, and it is the one we would give a healthy adult finishing a short course.
How long does the gut microbiome take to recover after antibiotics?
Longer than most people expect, and the honest answer is that it varies by person, drug and course length. What the Cell study adds is that the recovery trajectory itself can be altered by what you take: spontaneous recovery, autologous transplant and probiotics produced three different curves, and the probiotic one was the slowest.
Sources
- Suez J, Zmora N, Zilberman-Schapira G, et al. Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT. Cell, 2018. View study
- Esmaeilinezhad Z, Ghosh NR, Walsh CM, et al. Probiotics for the prevention of Clostridioides difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev, 2025. View study
- Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther, 2018. View study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
